NY's DOH Approves Enzo Biochem's Blood-Based Colorectal Cancer Risk Test

Enzo Biochem has announced the New York State Department of Health has approved Enzo Clinical Labs' use of the company's ColonSentry test, according to a news release.

 

The test uses RNA contained in blood to measure the level of the expression of seven genes and provide an assessment of a patient's risk of having colorectal cancer.

 

The test, which requires a small sample of blood, was originally developed by GeneNews.

 

Related Articles on Colorectal Cancer Prevention:

Ohio Gastroenterology Group Provides Free Colonoscopies to Uninsured

American College of Physicians Issues New Guidance for Colorectal Cancer Screening

Kentucky's Tri-State Gastroenterology Associates to Provide Free Colon Cancer Education Program

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast